Objective: The aim of this study was to examine the metabolism of a simple
dose, intravenously administered TRH bolus of 200 mu g, in patients with eu
thyroid sick syndrome (ESS).
Patients and Methods: A TRH test was performed on ten ESS patients and ten
controls upon admission (d1) and after recovery (d2), Blood samples were co
llected at 0, 10, 20 and 30 min after TRH injection. We analyzed the Volume
of distribution (V-d) the plasma clearance rate (PCR), the fractional clea
rance rate (FCR), the half-life (t(1/2)) and the TSH response to the inject
ion of TRH.
Results: All patients had lower tri-iodothyronine (T-3) levels compared wit
h controls (0.9 +/- 0.1 nmol/l vs 1.9 +/- 0.1 nmol/l; P < 0.0001; mean +/-
S.D.: paired t-test). In addition, the V-d (16.7 +/- 5.9/l vs 30.6 +/- 0.6/
l: P < 0.0005) and PCR (2.0 +/- 0.80 l/min vs 3.3 +/- 0.25 l/min; P < 0.000
5) were found statistically lowered in patients than in controls, whereas F
CR (0.119 +/- 0.01 per min vs 0.110 +/- 0.01 per min: P < 0.025) was found
increased in patients as opposed to controls, The t(1/2) Of exogenously adm
inistered TRH was increased in ESS compared with controls (7.2 +/- 0.7 min
vs 6.3 +/- 0.6 min: P < 0.005). TSH response to TRH was found significantly
repressed at 10, 20 and 30 min after TRH injection, On d2, these findings
had reverted to normal and no changes regarding the kinetics of TRH and the
response of TSH could be detected between patients and controls.
Conclusions: The results demonstrate an impairment of TRH metabolism in ESS
. The findings may suggest altered enzymatic activity, responsible for TRH
degradation in states of acute ESS. These changes might be involved in the
pathogenesis of ESS and represent part of an adaptive mechanism to this syn
drome.